Education
About Us
Working with TipRanks
Follow Us
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
See the Price Targets and Ratings of:
LEXX Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$5→$4
Buy
257.14%
Upside
Reiterated
07/29/25
Buy Recommendation for Lexaria Bioscience Based on Improved Safety Profile of DehydraTECH-semaglutideValuation and Risks. Our 12-month price target is derived from an estimated market value of the firm at $130M. This includes a discounted cash flow (DCF) analysis-based asset value of $130M for DehydraTECH-GLP-1, using a 15% discount rate and 2% terminal growth rate. We have conservatively excluded the cash position. Assigned probability of approval is 15%. Assuming 33M shares outstanding at the end of August 2026, this yields a value of approximately $4 per share.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$5→$4
Buy
257.14%
Upside
Reiterated
07/29/25
Buy Recommendation for Lexaria Bioscience Based on Improved Safety Profile of DehydraTECH-semaglutideValuation and Risks. Our 12-month price target is derived from an estimated market value of the firm at $130M. This includes a discounted cash flow (DCF) analysis-based asset value of $130M for DehydraTECH-GLP-1, using a 15% discount rate and 2% terminal growth rate. We have conservatively excluded the cash position. Assigned probability of approval is 15%. Assuming 33M shares outstanding at the end of August 2026, this yields a value of approximately $4 per share.
Best Analysts Covering Lexaria Bioscience
1 Month
xxx
Success Rate
3/5 ratings generated profit
Average Return
-1.34%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of -1.34% per trade.
3 Months
xxx
Success Rate
2/5 ratings generated profit
Average Return
-11.50%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -11.50% per trade.
1 Year
2 Years
xxx
Success Rate
1/5 ratings generated profit
Average Return
-41.30%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -41.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LEXX Analyst Recommendation Trends
Rating
Sep 24
Nov 24
Dec 24
Jan 25
Jul 25
Strong Buy
5
5
4
4
5
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
4
4
5
Each month's total comprises the sum of three months' worth of ratings.
LEXX Stock Forecast FAQ
What is LEXX’s average 12-month price target, according to analysts?
Currently, no data Available
What is LEXX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for LEXX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LEXX a Buy, Sell or Hold?
Lexaria Bioscience has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lexaria Bioscience’s price target?
Currently, no data Available
What do analysts say about Lexaria Bioscience?
Lexaria Bioscience’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of LEXX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.